Clenbuterol Injectable 0,2mg Swiss Healthcare

£42.00

Clenbuterol Injectable 0.2mg is a beta-2 agonist research compound supplied by Swiss Healthcare for in-vitro laboratory studies investigating metabolic processes and cellular responses in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Clenbuterol Injectable 0,2mg Swiss Healthcare
Clenbuterol Injectable 0,2mg Swiss Healthcare
£42.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Clenbuterol Injectable 0,: Compound Profile

Clenbuterol Injectable 0.2mg is a beta-2 adrenergic agonist formulated by Swiss Healthcare for advanced laboratory research applications. This injectable compound enables researchers to investigate cellular metabolic pathways and beta-adrenergic receptor interactions in controlled experimental conditions. Scientists studying metabolic modulation often examine this compound alongside other research chemicals available from Stroid UK Shop to understand complex biochemical mechanisms.

Laboratory Research Applications

Research institutions utilise Clenbuterol Injectable to study beta-2 receptor binding affinity and downstream signalling cascades in cellular models. Laboratory investigations focus on examining how this compound influences cyclic adenosine monophosphate (cAMP) levels and protein kinase A activation pathways. Researchers studying metabolic compounds often compare this injectable formulation with other research substances to evaluate differential receptor selectivity. The compound’s injectable delivery system allows for precise dosimetry control in experimental protocols, enabling researchers to study concentration-dependent responses in tissue culture systems.

Technical Specifications

Clenbuterol Injectable 0.2mg Research Specifications
Parameter Specification
Active Compound Clenbuterol Hydrochloride
Concentration 0.2mg/ml
Formulation Injectable Solution
Manufacturer Swiss Healthcare
CAS Number 21898-19-1
Molecular Formula C12H18Cl2N2O
Storage 2-8°C, Protected from Light
Purity Verify with Supplier

This research compound maintains stability under proper storage conditions, allowing extended experimental timeframes. Researchers comparing various methodologies often analyse this compound alongside selective androgen receptor modulators and peptide compounds to evaluate different receptor-mediated pathways in cellular research models.

Research Compliance

Clenbuterol Injectable 0.2mg Swiss Healthcare is supplied exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with institutional guidelines and applicable regulations when handling this compound in scientific studies.

Related